CHRNA7 and neoplasm: Many studies indicated that alpha7 nicotinic acet-ylcholine receptor (α7nAChR) had the promotion in tumor-induction, furthermore, the lower α7nAChR expression indicated less chemotherapeutic drugs resistance (Hajiasgharzadeh et al., 2020; Zhang et al., 2020; Zheng et al., 2020).